Eric Boutin is a digital health investor and serial entrepreneur. Previously, Eric was Founder and CEO of Evolve, a machine-learning mobile technology company, which was acquired by HubSpot (NYSE: HUBS). He was Founder and CEO of Good Start Genetics, a molecular diagnostics and women’s health company, which acquired by Invitae (NYSE: NVTA). He was Founder and VP of Corporate Development at Flex Pharma, a biopharmaceutical company developing treatments for neuromuscular disorders, which went on to IPO (NSADAQ: FLKS).
Eric was an Investor and Entrepreneur in Residence at Longwood Fund, where he focused on healthcare and life science deals. He was a Founder of the HBS Alumni Angels Association of Boston, which provides seed capital for local startup companies. He is also a Venture Partner at NexGen Venture Partners, a network of entrepreneurs who co-invest in early stage tech companies. Eric holds a B.A. from Duke University, and an M.B.A. from Harvard Business School. In his free time, he enjoys weightlifting, science fiction, live theater, 80s rock, and Boston sports.
Eric is a board observer at Aspen RxHealth, Cala Health, Flywheel, Freenome, Peptone, and RxVantage. He is based out of Cambridge, Massachusetts.